<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The treatment of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) has come a long way in regards to survival, with the majority of even the advanced stage patients being cured </plain></SENT>
<SENT sid="1" pm="."><plain>The prognosis for relapsed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> remains dismal, despite attempts to further intensify therapy </plain></SENT>
<SENT sid="2" pm="."><plain>We report on a patient with advanced stage <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> who relapsed in the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> while on therapy </plain></SENT>
<SENT sid="3" pm="."><plain>The patient was successfully treated with an intensified regimen based on a concentration times time (C x T) <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-directed model </plain></SENT>
<SENT sid="4" pm="."><plain>Our experience shows both the feasibility and efficacy of such an approach in a patient with an otherwise very poor prognosis </plain></SENT>
</text></document>